Comparing breast cancer risk assessment models (Q43734111)

26 November 2017

0 references

Comparing breast cancer risk assessment models (English)

1 reference

26 November 2017

risk assessment model

1 reference

Mitchell H Gail

1

1 reference

PubMed ID

20427429

26 November 2017

Phuong L Mai

series ordinal

2

1 reference

PubMed ID

20427429

26 November 2017

language of work or name

English

0 references

publication date

28 April 2010

1 reference

Journal of the National Cancer Institute

26 November 2017

1 reference

26 November 2017

102

1 reference

26 November 2017

10

1 reference

26 November 2017

665-668

1 reference

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

26 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

A breast cancer prediction model incorporating familial and personal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Predicting risk of breast cancer in postmenopausal women by hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Validation of a breast cancer risk assessment model in women with a positive family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Recent trends in breast cancer among younger women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Assessment of the accuracy of the Gail model in women with atypical hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

On criteria for evaluating models of absolute risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Decision curve analysis: a novel method for evaluating prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Lobular neoplasia. Long term risk of breast cancer and relation to other factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Applying the Lorenz curve to disease risk to optimize health benefits under cost constraints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

Performance of common genetic variants in breast-cancer risk models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ141

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJQ141

1 reference

26 November 2017

1 reference

PubMed ID

20427429